Jane Street Group, LLC Moderna, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 630,179 shares of MRNA stock, worth $25.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

630,179

Previous 1,314,499 52.06%

Holding current value

$25.9 Million

Previous $156 Million 73.02%

% of portfolio

0.01%

Previous 0.18%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$63.64 - $125.14 $43.6 Million - $85.6 Million	-684,320 Reduced 52.06%	630,179 $42.1 Million
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $83.1 Million - $137 Million	820,909 Added 166.31%	1,314,499 $156 Million
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $17.3 Million - $23.4 Million	-202,428 Reduced 29.08%	493,590 $52.6 Million
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $23.3 Million - $34.9 Million	334,530 Added 92.54%	696,018 $69.2 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $4.69 Million - $6.17 Million	48,698 Added 15.57%	361,488 $37.3 Million
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $88.2 Million - $119 Million	-744,200 Reduced 70.41%	312,790 $38 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $63.1 Million - $91.6 Million	464,961 Added 78.54%	1,056,990 $162 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $10.1 Million - $17.9 Million	85,189 Added 16.81%	592,029 $106 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $13.1 Million - $21.6 Million	111,046 Added 28.06%	506,840 $59.9 Million
Q2 2022 Aug 16, 2022	SELL	$117.13 - $176.59 $29 Million - $43.7 Million	-247,545 Reduced 38.48%	395,794 $56.5 Million
Q1 2022 May 17, 2022	SELL	$126.46 - $235.05 $88.1 Million - $164 Million	-696,531 Reduced 51.98%	643,339 $111 Million
Q4 2021 Feb 15, 2022	BUY	$225.82 - $368.51 $199 Million - $324 Million	879,448 Added 191.01%	1,339,870 $340 Million
Q3 2021 Nov 16, 2021	SELL	$221.9 - $484.47 $96.5 Million - $211 Million	-434,998 Reduced 48.58%	460,422 $177 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $82.4 Million - $149 Million	633,932 Added 242.43%	895,420 $210 Million
Q1 2021 May 18, 2021	SELL	$109.18 - $185.98 $57 Million - $97.1 Million	-522,079 Reduced 66.63%	261,488 $34.2 Million
Q4 2020 Feb 17, 2021	SELL	$65.74 - $169.86 $44.2 Million - $114 Million	-672,772 Reduced 46.2%	783,567 $81.9 Million
Q3 2020 Nov 17, 2020	BUY	$54.34 - $94.85 $14.7 Million - $25.6 Million	270,147 Added 22.77%	1,456,339 $103 Million
Q2 2020 Aug 17, 2020	BUY	$29.67 - $80.0 $34.2 Million - $92.1 Million	1,151,727 Added 3341.73%	1,186,192 $76.2 Million
Q1 2020 May 15, 2020	SELL	$17.78 - $31.58 $497,644 - $883,892	-27,989 Reduced 44.82%	34,465 $1.03 Million
Q4 2019 Feb 14, 2020	BUY	$13.93 - $21.28 $869,984 - $1.33 Million	62,454 New	62,454 $1.22 Million
Q1 2019 May 16, 2019	SELL	$14.45 - $23.7 $179,035 - $293,643	-12,390 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$13.52 - $18.8 $167,512 - $232,932	12,390 New	12,390 $189,000

Others Institutions Holding MRNA

# of Institutions

952

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.1B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Moderna, Inc. Transaction History